Linked banner for FIC 2026 in Shanghai, Mar 17–19, featuring grandfather and child with “Better lifelong health starts here” by Novonesis

Looking for a new barrier therapy for GERD?

June 2021

RefluG™ Isorepair is a patented class IIa medical device for the treatment of gastroesophageal reflux symptoms, available for out-licensing under private label. In ready-to-take liquid sachets, it exerts multiple mechanical actions on the esophageal mucosa surface (protective, soothing, lubricant). Its efficacy is proven in a randomized, double-blind placebo-controlled trial.

Image